Literature DB >> 24630811

DNA double-strand break repair in a cellular context.

A Shibata1, P A Jeggo2.   

Abstract

Substantial insight into the mechanisms responding to DNA double-strand breaks has been gained from molecular, biochemical and structural approaches. Attention is now focusing on understanding the interplay between the pathways, how they interface through the cell cycle and the communication with other DNA transactions, such as replication and transcription. Understanding these aspects will facilitate an assessment of how cancer cells have modified these processes to achieve unlimited proliferative capacity and adaptability, and pave the way to identify targets suitable for therapy. Here, we briefly overview the processes responding to double-strand breaks and discuss our current understanding of their interplay in a cellular context.
Copyright © 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA damage response signalling; DNA non-homologous end-joining; DSB repair; homologous recombination; radiation; radiotherapy

Mesh:

Year:  2014        PMID: 24630811     DOI: 10.1016/j.clon.2014.02.004

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  51 in total

1.  DNA damage-induced dynamic changes in abundance and cytosol-nuclear translocation of proteins involved in translational processes, metabolism, and autophagy.

Authors:  Martin V Bennetzen; Martin Kosar; Jakob Bunkenborg; Mark Ronald Payne; Jirina Bartkova; Mikael S Lindström; Jiri Lukas; Jens S Andersen; Jiri Bartek; Dorthe Helena Larsen
Journal:  Cell Cycle       Date:  2018-09-22       Impact factor: 4.534

2.  Restoration of ATM Expression in DNA-PKcs-Deficient Cells Inhibits Signal End Joining.

Authors:  Jessica A Neal; Yao Xu; Masumi Abe; Eric Hendrickson; Katheryn Meek
Journal:  J Immunol       Date:  2016-02-26       Impact factor: 5.422

3.  Differences in the recruitment of DNA repair proteins at subtelomeric and interstitial I-SceI endonuclease-induced DNA double-strand breaks.

Authors:  Bárbara Alcaraz Silva; Trevor J Jones; John P Murnane
Journal:  DNA Repair (Amst)       Date:  2016-11-05

4.  Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer.

Authors:  Bo Wook Kim; Hanbyoul Cho; Kris Ylaya; Haruhisa Kitano; Joon-Yong Chung; Stephen M Hewitt; Jae-Hoon Kim
Journal:  Anticancer Res       Date:  2017-09       Impact factor: 2.480

5.  Centrobin plays a role in the cellular response to DNA damage.

Authors:  Na Mi Ryu; Jung Min Kim
Journal:  Cell Cycle       Date:  2019-08-15       Impact factor: 4.534

6.  Characterization and phosphoproteomic analysis of a human immortalized podocyte model of Fabry disease generated using CRISPR/Cas9 technology.

Authors:  Ester M Pereira; Anatália Labilloy; Megan L Eshbach; Ankita Roy; Arohan R Subramanya; Semiramis Monte; Guillaume Labilloy; Ora A Weisz
Journal:  Am J Physiol Renal Physiol       Date:  2016-09-28

7.  The Ubiquitin E3/E4 Ligase UBE4A Adjusts Protein Ubiquitylation and Accumulation at Sites of DNA Damage, Facilitating Double-Strand Break Repair.

Authors:  Keren Baranes-Bachar; Adva Levy-Barda; Judith Oehler; Dylan A Reid; Isabel Soria-Bretones; Ty C Voss; Dudley Chung; Yoon Park; Chao Liu; Jong-Bok Yoon; Wei Li; Graham Dellaire; Tom Misteli; Pablo Huertas; Eli Rothenberg; Kristijan Ramadan; Yael Ziv; Yosef Shiloh
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

Review 8.  Systemic DNA damage responses in aging and diseases.

Authors:  Flavia Ribezzo; Yosef Shiloh; Björn Schumacher
Journal:  Semin Cancer Biol       Date:  2016-01-07       Impact factor: 15.707

Review 9.  PARP inhibitors in gastric cancer: beacon of hope.

Authors:  Yali Wang; Kun Zheng; Yongbiao Huang; Hua Xiong; Jinfang Su; Rui Chen; Yanmei Zou
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24

10.  TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.

Authors:  Silvia Maifrede; Bac Viet Le; Margaret Nieborowska-Skorska; Konstantin Golovine; Katherine Sullivan-Reed; Wangisa M B Dunuwille; Joseph Nacson; Michael Hulse; Kelsey Keith; Jozef Madzo; Lisa Beatrice Caruso; Zachary Gazze; Zhaorui Lian; Antonella Padella; Kumaraswamy N Chitrala; Boris A Bartholdy; Ksenia Matlawska-Wasowska; Daniela Di Marcantonio; Giorgia Simonetti; Georg Greiner; Stephen M Sykes; Peter Valent; Elisabeth M Paietta; Martin S Tallman; Hugo F Fernandez; Mark R Litzow; Mark D Minden; Jian Huang; Giovanni Martinelli; George S Vassiliou; Italo Tempera; Katarzyna Piwocka; Neil Johnson; Grant A Challen; Tomasz Skorski
Journal:  Cancer Res       Date:  2021-07-02       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.